Company Minerva Surgical, Inc.

Equities

UTRS

US60343F2056

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Quarterly earnings - Rate of surprise

Sector Medical Devices & Implants

Market Closed - OTC Markets Other stock markets 01:44:32 2024-04-18 pm EDT			5-day change	1st Jan Change
0.46 ^USD	-9.80%		-29.23%	-60.68%

Jan. 03	Minerva Surgical, Inc.(OTCPK:UTRS) dropped from S&P TMI Index	CI
2023	Minerva Surgical, Inc.(OTCPK:UTRS) dropped from NASDAQ Composite Index	CI

Minerva Surgical, Inc. is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. It has established a product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. Its Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies. It offers a range of solutions, such as the Minerva ES Endometrial Ablation System (Minerva ES), Genesys HTA Endometrial Ablation System (Genesys HTA), Symphion Tissue Removal System (Symphion), and Resectr Tissue Resection Device (Resectr). Minerva ES is an endometrial ablation device that utilizes its PlasmaSense technology.

Number of employees: 174

USD in Million	2021	Weight	2022	Weight	Delta
Abnormal Uterine Bleeding Therapeutic Devices 100.0 %	52	100.0 %	50	100.0 %	-3.47%

USD in Million	2021	Weight	2022	Weight	Delta
United States 100.0 %	52	100.0 %	50	100.0 %	-3.47%

Managers	Title	Age	Since
Todd Usen CEO	Chief Executive Officer	-	23-01-01
Joel R. Jung DFI	Director of Finance/CFO	66	20-06-30
Eugene V. Skalnyi CTO	Chief Tech/Sci/R&D Officer	58	10-12-31
Dominique J. Filloux COO	Chief Operating Officer	62	09-12-31
Caroline Corne IRC	Investor Relations Contact	-	-
Joanne Long AUD	Comptroller/Controller/Auditor	-	21-01-31
Wendy Bowman HRO	Human Resources Officer	-	14-12-31
Kaile Zagger PRN	Corporate Officer/Principal	-	23-03-20

Members of the board	Title	Age	Since
Uri Geiger CHM	Chairman	56	23-02-08
Derrick Sung BRD	Director/Board Member	51	22-07-19
Niquette L. Hunt BRD	Director/Board Member	59	21-05-31
Todd Usen CEO	Chief Executive Officer	-	23-01-01
Catherine Coste BRD	Director/Board Member	58	21-01-31
Daniel Cohen BRD	Director/Board Member	-	23-02-28

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	8,878,582	2,731,338 ( 30.76 %)	0	30.76 %

Name	Equities	%	Valuation
A.M. Accelmed Management (2009) Ltd. 68.81 %	6,109,482	68.81 %	4 M $
NEA Management Co. LLC 19.39 %	1,721,853	19.39 %	1 M $
CVF LLC 1.273 %	112,985	1.273 %	70 616 $
Versant Venture Management LLC 0.9679 %	85,938	0.9679 %	53 711 $
Dominique J. Filloux 0.1400 %	12,431	0.1400 %	7 769 $
Ross Jaffe 0.0744 %	6,605	0.0744 %	4 128 $
Catherine Coste 0.0669 %	5,940	0.0669 %	3 713 $
Joel R. Jung 0.0571 %	5,072	0.0571 %	3 170 $
Ali Behbahani 0.0258 %	2,292	0.0258 %	1 433 $
Jill Anderson 0.0210 %	1,867	0.0210 %	1 167 $

Minerva Surgical, Inc.

4255 Burton Drive

95054, Santa Clara

http://minervasurgical.com

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Medical Devices & Implants

	1st Jan change	Capi.
MINERVA SURGICAL, INC.	-60.68%	4.53M
STRYKER CORPORATION	+9.35%	128B
SMITH & NEPHEW PLC	-10.36%	10.42B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-1.13%	8.81B
INSPIRE MEDICAL SYSTEMS, INC.	+18.54%	7.38B
GLAUKOS CORPORATION	+19.68%	4.86B
AXONICS, INC.	+7.75%	3.43B
ENOVIS CORPORATION	-1.34%	3.08B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-16.08%	2.01B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-12.31%	1.96B

Medical Devices & Implants